The International Parkinson and Movement Disorder Society-European Section (MDS-ES)

The International Parkinson and Movement Disorder Society (MDS) is a professional society of clinicians, scientists, and other healthcare professionals who are interested in Parkinson's disease, related neurodegenerative and neurodevelopmental disorders, hyperkinetic movement disorders, and abnormalities in muscle tone and motor control.

The assistance of their members, who work tirelessly to help further the Society's mission, enables MDS to educate and inform others around the world about the latest news, research, and advances in movement disorders.

Mission and Goals:
The International Parkinson and Movement Disorder Society is a professional society of clinicians, scientists, and other healthcare professionals who are interested in Parkinson's disease, related neurodegenerative and neurodevelopmental disorders, hyperkinetic Movement Disorders and abnormalities in muscle tone and motor control.
To disseminate knowledge about movement disorders by:
• Providing educational programs for clinicians, scientists and the general public designed to advance scientific and clinical knowledge about movement disorders
• Sponsoring International Congresses and Symposia on movement disorders
• Collaborating with other international organizations and lay groups
• Publishing journals, videos, and other collateral materials committed to high scientific standards and peer review

To promote research into causes, prevention and treatment of Movement Disorders by:
• Using the Society's influence and resources to enhance support for research
• Facilitating the dissemination of information about research
• Encouraging the training of basic and clinical scientists in movement disorders and related disorders

For the purposes of favorably affecting the care of patients with movement disorders, the Society will provide expertise, advice and guidance to:
• Regulatory agencies to assist them in the approval process of safe and effective therapeutic interventions
• The public (media) and patient support groups by informing them of new research and therapeutic advances
• Governments to assist them in the development of policies that affect support of research and patient care
• Educational efforts to assist in developing standards of training in the specialty